All Stories

  1. The difficult road to new vaccines for pertussis and serogroup B meningococcal disease

    Article • Journal of Chemical Technology & Biotechnology, August 2015, Wiley

    Professor Andrew R Gorringe

  2. Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England

    Article • Clinical and Vaccine Immunology, March 2015, ASM Journals

    Professor Andrew R Gorringe

  3. Antibody-Mediated Complement C3b/iC3b Binding to Group B Streptococcus in Paired Mother and Baby Serum Samples in a Refugee Population on the Thailand-Myanmar Border

    Article • Clinical and Vaccine Immunology, January 2015, ASM Journals

    Professor Andrew R Gorringe

  4. Anti-Group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection

    Article • Vaccine, January 2015, Elsevier

    Professor Andrew R Gorringe

  5. Genomic Analysis of Isolates From the United Kingdom 2012 Pertussis Outbreak Reveals That Vaccine Antigen Genes Are Unusually Fast Evolving

    Article • The Journal of Infectious Diseases, December 2014, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  6. Bordetella pertussisfimbriae (Fim): relevance for vaccines

    Article • Expert Review of Vaccines, August 2014, Taylor & Francis

    Professor Andrew R Gorringe

  7. Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing

    Article • Microbiology, July 2014, Society for General Microbiology

    Professor Andrew R Gorringe

  8. Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis

    Article • Journal of Proteomics, April 2014, Elsevier

    Professor Andrew R Gorringe

  9. Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

    Article • Clinical and Vaccine Immunology, December 2013, ASM Journals

    Professor Andrew R Gorringe

  10. Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease

    Article • Clinical and Vaccine Immunology, September 2012, ASM Journals

    Professor Andrew R Gorringe

  11. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis

    Article • Vaccine, March 2012, Elsevier

    Professor Andrew R Gorringe

  12. Structural basis for iron piracy by pathogenic Neisseria

    Article • Nature, February 2012, Springer Science + Business Media

    Professor Andrew R Gorringe

  13. From pertussis to meningococcal disease and back

    Article • Human Vaccines, April 2011, Taylor & Francis

    Professor Andrew R Gorringe

  14. Nasopharyngeal Colonization by Neisseria lactamica and Induction of Protective Immunity against Neisseria meningitidis

    Article • Clinical Infectious Diseases, January 2011, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  15. Neisseria lactamica Selectively Induces Mitogenic Proliferation of the Naive B Cell Pool via Cell Surface Ig

    Article • The Journal of Immunology, August 2010, The American Association of Immunologists

    Professor Andrew R Gorringe

  16. Assessment of vaccine potential of the Neisseria-specific protein NMB0938

    Article • Vaccine, November 2009, Elsevier

    Professor Andrew R Gorringe

  17. Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles

    Article • Clinical and Vaccine Immunology, June 2009, ASM Journals

    Professor Andrew R Gorringe

  18. Absence of Mucosal Immunity in the Human Upper Respiratory Tract to the Commensal Bacteria Neisseria lactamica but Not Pathogenic Neisseria meningitidis during the Peak Age of Nasopharyngeal Carriage

    Article • The Journal of Immunology, February 2009, The American Association of Immunologists

    Professor Andrew R Gorringe

  19. 16th International Pathogenic Neisseria Conference: Recent progress towards effective meningococcal disease vaccines

    Article • Human Vaccines, February 2009, Taylor & Francis

    Professor Andrew R Gorringe

  20. A Neisseria meningitidis NMB1966 mutant is impaired for invasion of respiratory epithelial cells, survival in human blood and for virulence in vivo

    Article • Medical Microbiology and Immunology, December 2008, Springer Science + Business Media

    Dr Ming-Shi Li, Professor Andrew R Gorringe

  21. Pilot study of human experimental challenge with neisseria lactamica

    Article • Journal of Infection, November 2008, Elsevier

    Professor Andrew R Gorringe

  22. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based onNeisseria lactamicaouter membrane vesicles

    Article • Human Vaccines, January 2008, Taylor & Francis

    Professor Andrew R Gorringe

  23. Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac

    Article • Infection and Immunity, July 2007, ASM Journals

    Professor Andrew R Gorringe

  24. Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B

    Article • Vaccine, July 2007, Elsevier

    Professor Andrew R Gorringe

  25. Immunization with Live Neisseria lactamica Protects Mice against Meningococcal Challenge and Can Elicit Serum Bactericidal Antibodies

    Article • Infection and Immunity, September 2006, ASM Journals

    Professor Andrew R Gorringe

  26. Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac

    Article • Infection and Immunity, August 2006, ASM Journals

    Professor Andrew R Gorringe

  27. Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens

    Article • Vaccine, June 2006, Elsevier

    Professor Andrew R Gorringe

  28. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis

    Article • FEMS Immunology & Medical Microbiology, January 2006, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  29. Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant

    Article • Vaccine, January 2006, Elsevier

    Professor Andrew R Gorringe

  30. CanNeisseria lactamicaantigens provide an effective vaccine to prevent meningococcal disease?

    Article • Expert Review of Vaccines, June 2005, Taylor & Francis

    Professor Andrew R Gorringe

  31. Homology modelling of transferrin-binding protein A from Neisseria meningitidis

    Article • Protein Engineering Design and Selection, April 2005, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  32. Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI–TOF-MS (surface-enhanced laser desorption ionization–time-of-flight MS) for use in a meningococcal vaccine

    Article • Biotechnology and Applied Biochemistry, April 2005, Wiley

    Professor Andrew R Gorringe

  33. Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential

    Article • Infection and Immunity, November 2004, ASM Journals

    Professor Andrew R Gorringe

  34. Infection with an Avirulent phoP Mutant of Neisseria meningitidis Confers Broad Cross-Reactive Immunity

    Article • Infection and Immunity, January 2004, ASM Journals

    Professor Andrew R Gorringe

  35. Insight into the Structure and Function of the Transferrin Receptor from Neisseria meningitidis Using Microcalorimetric Techniques

    Article • Journal of Biological Chemistry, February 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Andrew R Gorringe

  36. Neisseria lactamica Protects against Experimental Meningococcal Infection

    Article • Infection and Immunity, July 2002, ASM Journals

    Professor Andrew R Gorringe

  37. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines

    Article • FEMS Immunology & Medical Microbiology, August 2001, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  38. Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines

    Article • Vaccine, May 2001, Elsevier

    Professor Andrew R Gorringe

  39. Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis

    Article • Molecular Microbiology, March 2001, Wiley

    Lesley-Jane Eales-Reynolds, Professor Andrew R Gorringe

  40. Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection

    Article • Infection and Immunity, March 2001, ASM Journals

    Professor Andrew R Gorringe

  41. Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis

    Article • Molecular Microbiology, March 2001, Wiley

    Professor Andrew R Gorringe

  42. Analysis of the human Ig isotype response to lactoferrin binding protein A from Neisseria meningitidis

    Article • FEMS Immunology & Medical Microbiology, September 1999, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  43. Blocking of iron uptake by monoclonal antibodies specific for the Neisseria meningitidis transferrin-binding protein 2

    Article • Journal of Medical Microbiology, October 1996, Society for General Microbiology

    Professor Andrew R Gorringe

  44. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model

    Article • Microbial Pathogenesis, November 1993, Elsevier

    Professor Andrew R Gorringe

  45. An Investigation into the Human Immune Response to B. pertussis Iron-regulated Proteins in Convalescent and Immune Sera

    Article • Biologicals, March 1993, Elsevier

    Professor Andrew R Gorringe

  46. Intranasal infection of infant mice with Neisseria meningitidis

    Article • Microbial Pathogenesis, June 1992, Elsevier

    Professor Andrew R Gorringe

  47. Growth and siderophore production by Bordetella pertussis under iron-restricted conditions

    Article • FEMS Microbiology Letters, January 1990, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  48. Growth and siderophore production by Bordetella pertussis under iron-restricted conditions

    Article • FEMS Microbiology Letters, January 1990, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  49. Serospecific protection of mice against intranasal infection with Bordetella pertussis

    Article • Vaccine, August 1989, Elsevier

    Professor Andrew R Gorringe

  50. The effect of methyl-β-cyclodextrin on the stability of Bordetella pertussis filamentous haemagglutinin

    Article • FEMS Microbiology Letters, October 1988, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  51. The effect of methyl-β-cyclodextrin on the stability of Bordetella pertussis filamentous haemagglutinin

    Article • FEMS Microbiology Letters, October 1988, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  52. Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells

    Article • FEMS Microbiology Letters, January 1985, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  53. Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells

    Article • FEMS Microbiology Letters, January 1985, Oxford University Press (OUP)

    Professor Andrew R Gorringe

  54. Antigenic modulation of Bordetella pertussis in continuous culture

    Article • FEMS Microbiology Letters, June 1983, Oxford University Press (OUP)

    Professor Andrew R Gorringe